Skin-isolated, community-acquired Staphylococcus aureus: In vitro resistance to methicillin and erythromycin

Nissim Ohana; Joram Keness; Ehud Verner; Raul Raz; Dganit Rozenman; Fela Zuckerman

doi:10.1016/S0190-9622(89)70223-1

Skin-isolated, community-acquired Staphylococcus aureus: In vitro resistance to methicillin and erythromycin

Nissim Ohana^*, Joram Keness, Ehud Verner, Raul Raz, Dganit Rozenman, Fela Zuckerman

^*Corresponding author for this work

Emek Medical Center

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Abstract

During a 10-month period, skin culture specimens were taken from 1680 healthy outpatients with a variety of community-acquired skin infections. Staphylococcus aureus was found in 1035 (61.6%) of these patients. In vitro resistance to methicillin and erythromycin was 1.0% and 42.9%, respectively. Resistance rates to erythromycin in patients with furunculosis and impetigo were 51.5% and 26.2%, respectively (p < 0.001).The emergence of erythromycinresistant strains may be the result of widespread use of this drug in our geographic area. There is also the possibility that certain bacteriologic features associated with erythromycin resistance may foster the development of furunculosis.

Original language	English
Pages (from-to)	544-546
Number of pages	3
Journal	Journal of the American Academy of Dermatology
Volume	21
Issue number	3
DOIs	https://doi.org/10.1016/S0190-9622(89)70223-1
State	Published - 1989
Externally published	Yes

Access to Document

10.1016/S0190-9622(89)70223-1

Cite this

@article{e767af33b1564dd88e3b4329816d11e8,

title = "Skin-isolated, community-acquired Staphylococcus aureus: In vitro resistance to methicillin and erythromycin",

abstract = "During a 10-month period, skin culture specimens were taken from 1680 healthy outpatients with a variety of community-acquired skin infections. Staphylococcus aureus was found in 1035 (61.6%) of these patients. In vitro resistance to methicillin and erythromycin was 1.0% and 42.9%, respectively. Resistance rates to erythromycin in patients with furunculosis and impetigo were 51.5% and 26.2%, respectively (p < 0.001).The emergence of erythromycinresistant strains may be the result of widespread use of this drug in our geographic area. There is also the possibility that certain bacteriologic features associated with erythromycin resistance may foster the development of furunculosis.",

author = "Nissim Ohana and Joram Keness and Ehud Verner and Raul Raz and Dganit Rozenman and Fela Zuckerman",

year = "1989",

doi = "10.1016/S0190-9622(89)70223-1",

language = "אנגלית",

volume = "21",

pages = "544--546",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Skin-isolated, community-acquired Staphylococcus aureus

T2 - In vitro resistance to methicillin and erythromycin

AU - Ohana, Nissim

AU - Keness, Joram

AU - Verner, Ehud

AU - Raz, Raul

AU - Rozenman, Dganit

AU - Zuckerman, Fela

PY - 1989

Y1 - 1989

N2 - During a 10-month period, skin culture specimens were taken from 1680 healthy outpatients with a variety of community-acquired skin infections. Staphylococcus aureus was found in 1035 (61.6%) of these patients. In vitro resistance to methicillin and erythromycin was 1.0% and 42.9%, respectively. Resistance rates to erythromycin in patients with furunculosis and impetigo were 51.5% and 26.2%, respectively (p < 0.001).The emergence of erythromycinresistant strains may be the result of widespread use of this drug in our geographic area. There is also the possibility that certain bacteriologic features associated with erythromycin resistance may foster the development of furunculosis.

AB - During a 10-month period, skin culture specimens were taken from 1680 healthy outpatients with a variety of community-acquired skin infections. Staphylococcus aureus was found in 1035 (61.6%) of these patients. In vitro resistance to methicillin and erythromycin was 1.0% and 42.9%, respectively. Resistance rates to erythromycin in patients with furunculosis and impetigo were 51.5% and 26.2%, respectively (p < 0.001).The emergence of erythromycinresistant strains may be the result of widespread use of this drug in our geographic area. There is also the possibility that certain bacteriologic features associated with erythromycin resistance may foster the development of furunculosis.

UR - http://www.scopus.com/inward/record.url?scp=0024464888&partnerID=8YFLogxK

U2 - 10.1016/S0190-9622(89)70223-1

DO - 10.1016/S0190-9622(89)70223-1

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 2789236

AN - SCOPUS:0024464888

SN - 0190-9622

VL - 21

SP - 544

EP - 546

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 3

ER -

Skin-isolated, community-acquired Staphylococcus aureus: In vitro resistance to methicillin and erythromycin

Abstract

Access to Document

Other files and links

Fingerprint

Cite this